Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I0DQ
|
|||
| Former ID |
DIB004492
|
|||
| Drug Name |
Glisolamide
|
|||
| Synonyms |
Glisolamide; Glysolamide; Diabenor; Glisolamide [INN]; Glisolamidum [INN-Latin]; Glisolamida [INN-Spanish]; UNII-F83U6T74XR; 24477-37-0; BRN 1050609; F83U6T74XR; P.M. 434,526; Glisolamide (INN); 1-Cyclohexyl-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea; N-(4-(beta-(5-Metilossazol-3-carbossamido)-etil)-benzenesolfonil)-N(sup 1)-cicloesil-urea; N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-3-isoxazolecarboxamide; Glisolamidum; Glisolamida; Urea, 1-cyclohexyl-3-((p-(2-(5-met
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H26N4O5S
|
|||
| Canonical SMILES |
CC1=CC(=NO1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
|
|||
| InChI |
1S/C20H26N4O5S/c1-14-13-18(23-29-14)19(25)21-12-11-15-7-9-17(10-8-15)30(27,28)24-20(26)22-16-5-3-2-4-6-16/h7-10,13,16H,2-6,11-12H2,1H3,(H,21,25)(H2,22,24,26)
|
|||
| InChIKey |
GZKDXUIWCNCNBJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 24477-37-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:135707
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.